Small Business

Motilal Oswal profit rises 74% to Rs 47cr

Motilal Oswal Financial Services reported a 74 per cent year-on-year growth in net profit to Rs 47.2 crore for the quarter ended September 30, 2009. - Sunil Jain: In the black">Sunil Jain: In the black - Parsvnath Q2 net up three fold to Rs 61.43 cr - Banco Products net up 99% at Rs 21-cr - Indusind Bank Q2 net zooms 131% at Rs 77.8 cr - HDFC Bank Q2 net jumps 30% at Rs 687.46 cr - Mid & small-cap firms to see single-digit growth On a quarter-on-quarter basis, net profit grew by 31 per cent. Broking and related revenues were up 31 per cent to Rs 125.3 crore as compared to Rs 95.6 crore in the corresponding quarter last year. Investment Banking fees were down 8 per cent to Rs 15.2 crore as against Rs 16.5 crore in the year-ago quarter. Asset management fees were up 26 per cent to Rs 6.4 crore as compared to Rs 5.1 crore in the same quarter of the previous year.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Doing everything to make sure Pak smashes terror groups: US
The US today said it was "doing everything" to make sure that Pakistan smashes terror groups like Lashkar-e-Toiba and denies them safe havens, as India remembered 183 people who fell to terrorists" bullets in attacks on Mumbai exactly a year ago.
Popular Articles
payday loan lenders

Ethical indices outdo benchmarks
Even as socially responsible investing (SRI) is yet to find its feet in India, indices that screen stocks based on ethical and environmental concerns have been outperforming their benchmark peers.

Glenmark Generics launches hypertension drug in US
Glenmark Generics Ind, USA (GGI), the US subsidiary of Glenmark Generics and a leading company in the manufacture, marketing and distribution of high-quality, low-cost generic pharmaceutical products in the US, initiated the launch of Fosinopril Sodium and Hydrochlorothiazide tablets in the US market.

© Copyright 2009